On July 27th, 2023, the 75th ADLM (formerly AACC Annual Clinical Lab Expo and Clinical Laboratory Medicine Conference) successfully concluded at the Anaheim Convention Center in California, USA.
The AACC Annual Clinical Lab Expo is one of the highest quality and largest annual events in the clinical laboratory field worldwide. It is also one of the most important international academic conferences and medical equipment exhibitions for clinical diagnostics globally. This year’s expo attracted over 941 exhibitors from more than 100 countries and regions.
As a leading company in China’s in-vitro diagnostics (IVD) industry, Tellgen brought many flagship products and made an impressive showing at Booth #1389. Among them, the fully automated chemiluminescence immunoassay analyzer TESMI i200 garnered significant attention from numerous scholars, experts and distributors.
TESMI i200
Runs Continuously Without Interruption
The Tellgen TESMI i200 is a high-speed, fully automated chemiluminescence immunoassay analyzer. With advanced technology and innovative design integrating strengths from various fields, the TESMI i200 is equipped with 4 external reagent automatic changing modules, enabling uninterrupted reagent changing without stopping the workflow. It achieves a testing speed of 480 tests/hour, realizing the new fully automatic reagent changing mode of “No Downtime – No Interruption – No Waiting”, allowing “Continuous Operation Without Interruption”.
The TESMI i200 can run over 70 different diagnostic tests including liver and kidney function, cardiac markers, tumor markers, hormones, etc. Notably, Tellgen’s liver function reagents demonstrate superior quality, utilizing an acridinium ester chemiluminescence method with CV<3%, comparable to international standards. The excellent stability of the TESMI i200 enables more efficient and reliable clinical diagnostics.
The TESMI i200 utilizes a modular design, with up to 4 instruments connected, achieving a maximum throughput of 3360 tests/hour. The TESMI i200 can be combined with Tellgen’s flow fluorescence technology platform and T6 pre-analytical system to create Tellgen’s unique direct-connected immunodiagnostic workflow. The flexible combination of the two instruments can detect over 100 immunological parameters. Paired with the 1.3m wide T6 pre-analytical system, this high-efficiency, compact workflow truly achieves “Space-saving Automation”.
At the exhibition, the powerful capabilities and superior performance of the TESMI i200 garnered significant attention from numerous scholars, experts and distributors. Many visitors converged at the Tellgen booth, gaining an in-depth understanding of the TESMI i200’s technical attributes and application strengths through interaction with the technical team. Many participating scholars and experts also engaged in productive discussions and exchanges regarding the system’s capabilities and applications.
Throughout the exhibition, Tellgen showcased its extensive expertise and culture of innovation cultivated in the biomedical field over the years. The introduction of the TESMI i200 and the strength of its automated solutions underscored Tellgen’s leading position in the global life science instrumentation arena.
We sincerely appreciate your interest in Tellgen and the TESMI i200. We remain committed to continuous innovation, providing more high-quality products and services for the global scientific research and clinical diagnostic communities. Please follow our WeChat official account for more exhibition updates and news on our latest product developments.
See you in Chicago McCormick Place convention center in 2024!
